Last 12 months
Inside the activity.
0 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 28, 2021 Filed Sep 30, 2021 20:23 UTC |
Buchholz RichardChief Financial Officer
|
Exercise / conversionCommon Stock | 2,819 | $10.38 | $29,261.22 |
DisclosureSEC source: 0001104659-21-121240 · tm2128930-1_4seq1.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,295 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 28, 2021 Filed Sep 30, 2021 20:23 UTC |
Buchholz RichardChief Financial Officer
|
Exercise / conversionCommon Stock | 1,607 | $42.15 | $67,735.05 |
DisclosureSEC source: 0001104659-21-121240 · tm2128930-1_4seq1.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 80 shares acquired under the Company's 2018 Employee Stock Purchase Plan since the date of the reporting person's last ownership report. Read SEC document |
| September 02, 2021 Filed Jan 27, 2022 01:52 UTC |
Herbert Timothy P.Director · CEO and President
|
GiftCommon Stock | 3,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-007937 · tm224511-1_4seq1.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 5,224 F1 · ownership.nature: Shares held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 22:09 UTC |
Melenikiotou GeorgiaDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 426 | $0.00 Strike: $93.14 | $0.00 |
DisclosureSEC source: 0001104659-21-109031 · tm2125754-1_4seq1.xml · derivative · entry 4 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,556 Underlying: Common Stock · 426 shares Expires 2030-07-08 F1 · derivative.exercise_date: The original 3,834 shares underlying the option have vested or will vest and become exercisable in three equal annual installments that began on July 8, 2021, subject to the Non-Employee Director continuing in service through each applicable vesting date. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 22:09 UTC |
Melenikiotou GeorgiaDirector
|
SaleCommon Stock | 140 | $212.00 | $29,680.00 |
DisclosureSEC source: 0001104659-21-109031 · tm2125754-1_4seq1.xml · nonDerivative · entry 3 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 22:09 UTC |
Melenikiotou GeorgiaDirector
|
SaleCommon Stock | 426 | $212.29 | $90,435.54 |
DisclosureSEC source: 0001104659-21-109031 · tm2125754-1_4seq1.xml · nonDerivative · entry 2 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140 Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 22:09 UTC |
Melenikiotou GeorgiaDirector
|
Exercise / conversionCommon Stock | 426 | $93.14 | $39,677.64 |
DisclosureSEC source: 0001104659-21-109031 · tm2125754-1_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 566 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2021 Filed Aug 20, 2021 20:05 UTC |
Melenikiotou GeorgiaDirector
|
SaleCommon Stock | 140 | $206.97 | $28,975.80 |
DisclosureSEC source: 0001104659-21-108154 · tm2125596-1_4seq1.xml · nonDerivative · entry 3 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140 Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 20:05 UTC |
Melenikiotou GeorgiaDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 852 | $0.00 Strike: $93.14 | $0.00 |
DisclosureSEC source: 0001104659-21-108154 · tm2125596-1_4seq1.xml · derivative · entry 4 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,982 Underlying: Common Stock · 852 shares Expires 2030-07-08 F2 · derivative.exercise_date: The original 3,834 shares underlying the option have vested or will vest and become exercisable in three equal annual installments that began on July 8, 2021, subject to the Non-Employee Director continuing in service through each applicable vesting date. Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 20:05 UTC |
Melenikiotou GeorgiaDirector
|
SaleCommon Stock | 852 | $207.08 | $176,432.16 |
DisclosureSEC source: 0001104659-21-108154 · tm2125596-1_4seq1.xml · nonDerivative · entry 2 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.96 to $207.20. The reporting person undertakes to provide the Company, any security holder of Inspire Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 20:05 UTC |
Melenikiotou GeorgiaDirector
|
Exercise / conversionCommon Stock | 852 | $93.14 | $79,355.28 |
DisclosureSEC source: 0001104659-21-108154 · tm2125596-1_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,132 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 09, 2021 Filed Jul 13, 2021 21:10 UTC |
Melenikiotou GeorgiaDirector
|
GrantCommon Stock | 71 | $185.73 | $13,186.83 |
DisclosureSEC source: 0001104659-21-091745 · tm2122094-3_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| July 09, 2021 Filed Jul 13, 2021 21:12 UTC |
Broader Shelley GDirector
|
GrantCommon Stock | 68 | $185.73 | $12,629.64 |
DisclosureSEC source: 0001104659-21-091751 · tm2122094-5_4seq1.xml · nonDerivative · entry 1 Broader Shelley G. · CIK 0001426843 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| July 09, 2021 Filed Jul 13, 2021 21:11 UTC |
NELSON MARILYN CDirector
|
GrantCommon Stock | 120 | $185.73 | $22,287.60 |
DisclosureSEC source: 0001104659-21-091748 · tm2122094-4_4seq1.xml · nonDerivative · entry 1 NELSON MARILYN C · CIK 0001199894 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,509 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| July 09, 2021 Filed Jul 13, 2021 21:08 UTC |
Ellis Gary LeeDirector
|
GrantCommon Stock | 78 | $185.73 | $14,486.94 |
DisclosureSEC source: 0001104659-21-091740 · tm2122094-2_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,846 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| July 09, 2021 Filed Jul 13, 2021 21:05 UTC |
Tansey Casey MDirector
|
GrantCommon Stock | 78 | $185.73 | $14,486.94 |
DisclosureSEC source: 0001104659-21-091736 · tm2122094-1_4seq1.xml · nonDerivative · entry 1 Tansey Casey M · CIK 0001474322 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,145 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| April 29, 2021 Filed May 3, 2021 21:14 UTC |
Melenikiotou GeorgiaDirector
|
GrantStock Option (right to buy) · Derivative | 1,175 | $0.00 Strike: $240.68 | $0.00 |
DisclosureSEC source: 0001104659-21-060313 · tm2114992-4_4seq1.xml · derivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,175 Underlying: Common Stock · 1,175 shares Expires 2031-04-29 F1 · derivative.exercise_date: The option vests and becomes exercisable on April 29, 2022, subject to the Reporting Person's continuous service to the Issuer through such date. Read SEC document |
| April 29, 2021 Filed May 3, 2021 21:23 UTC |
Broader Shelley GDirector
|
GrantStock Option (right to buy) · Derivative | 1,175 | $0.00 Strike: $240.68 | $0.00 |
DisclosureSEC source: 0001104659-21-060333 · tm2114992-8_4seq1.xml · derivative · entry 1 Broader Shelley G. · CIK 0001426843 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,175 Underlying: Common Stock · 1,175 shares Expires 2031-04-29 F1 · derivative.exercise_date: The option vests and becomes exercisable on April 29, 2022, subject to the Reporting Person's continuous service to the Issuer through such date. Read SEC document |
| April 29, 2021 Filed May 3, 2021 21:20 UTC |
mcCormick ShawnDirector
|
GrantStock Option (right to buy) · Derivative | 1,175 | $0.00 Strike: $240.68 | $0.00 |
DisclosureSEC source: 0001104659-21-060326 · tm2114992-7_4seq1.xml · derivative · entry 1 McCormick Shawn · CIK 0001454092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,175 Underlying: Common Stock · 1,175 shares Expires 2031-04-29 F1 · derivative.exercise_date: The option vests and becomes exercisable on April 29, 2022, subject to the Reporting Person's continuous service to the Issuer through such date. Read SEC document |
| April 29, 2021 Filed May 3, 2021 21:16 UTC |
NELSON MARILYN CDirector
|
GrantStock Option (right to buy) · Derivative | 1,175 | $0.00 Strike: $240.68 | $0.00 |
DisclosureSEC source: 0001104659-21-060319 · tm2114992-6_4seq1.xml · derivative · entry 1 NELSON MARILYN C · CIK 0001199894 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,175 Underlying: Common Stock · 1,175 shares Expires 2031-04-29 F1 · derivative.exercise_date: The option vests and becomes exercisable on April 29, 2022, subject to the Reporting Person's continuous service to the Issuer through such date. Read SEC document |
| April 29, 2021 Filed May 3, 2021 21:15 UTC |
Griffin Jerry CDirector
|
GrantStock Option (right to buy) · Derivative | 1,175 | $0.00 Strike: $240.68 | $0.00 |
DisclosureSEC source: 0001104659-21-060317 · tm2114992-5_4seq1.xml · derivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,175 Underlying: Common Stock · 1,175 shares Expires 2031-04-29 F1 · derivative.exercise_date: The option vests and becomes exercisable on April 29, 2022, subject to the Reporting Person's continuous service to the Issuer through such date. Read SEC document |
| April 29, 2021 Filed May 3, 2021 21:13 UTC |
Ellis Gary LeeDirector
|
GrantStock Option (right to buy) · Derivative | 1,175 | $0.00 Strike: $240.68 | $0.00 |
DisclosureSEC source: 0001104659-21-060307 · tm2114992-3_4seq1.xml · derivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,175 Underlying: Common Stock · 1,175 shares Expires 2031-04-29 F1 · derivative.exercise_date: The option vests and becomes exercisable on April 29, 2022, subject to the Reporting Person's continuous service to the Issuer through such date. Read SEC document |
| April 29, 2021 Filed May 3, 2021 21:10 UTC |
Mead Dana G Jr.Director
|
GrantStock Option (right to buy) · Derivative | 1,175 | $0.00 Strike: $240.68 | $0.00 |
DisclosureSEC source: 0001104659-21-060305 · tm2114992-2_4seq1.xml · derivative · entry 1 Mead Dana G Jr. · CIK 0001222358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,175 Underlying: Common Stock · 1,175 shares Expires 2031-04-29 F1 · derivative.exercise_date: The option vests and becomes exercisable on April 29, 2022, subject to the Reporting Person's continuous service to the Issuer through such date. Read SEC document |
| April 29, 2021 Filed May 3, 2021 21:09 UTC |
Tansey Casey MDirector
|
GrantStock Option (right to buy) · Derivative | 1,175 | $0.00 Strike: $240.68 | $0.00 |
DisclosureSEC source: 0001104659-21-060303 · tm2114992-1_4seq1.xml · derivative · entry 1 Tansey Casey M · CIK 0001474322 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,175 Underlying: Common Stock · 1,175 shares Expires 2031-04-29 F1 · derivative.exercise_date: The option vests and becomes exercisable on April 29, 2022, subject to the Reporting Person's continuous service to the Issuer through such date. Read SEC document |
| April 09, 2021 Filed Apr 13, 2021 20:16 UTC |
Melenikiotou GeorgiaDirector
|
GrantCommon Stock | 57 | $218.45 | $12,451.65 |
DisclosureSEC source: 0001104659-21-049764 · tm2112723-3_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| April 09, 2021 Filed Apr 13, 2021 20:17 UTC |
Broader Shelley GDirector
|
GrantCommon Stock | 54 | $218.45 | $11,796.30 |
DisclosureSEC source: 0001104659-21-049768 · tm2112723-5_4seq1.xml · nonDerivative · entry 1 Broader Shelley G. · CIK 0001426843 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| April 09, 2021 Filed Apr 13, 2021 20:16 UTC |
NELSON MARILYN CDirector
|
GrantCommon Stock | 94 | $218.45 | $20,534.30 |
DisclosureSEC source: 0001104659-21-049767 · tm2112723-4_4seq1.xml · nonDerivative · entry 1 NELSON MARILYN C · CIK 0001199894 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,389 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| April 09, 2021 Filed Apr 13, 2021 20:15 UTC |
Ellis Gary LeeDirector
|
GrantCommon Stock | 62 | $218.45 | $13,543.90 |
DisclosureSEC source: 0001104659-21-049762 · tm2112723-2_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,768 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| April 09, 2021 Filed Apr 13, 2021 20:15 UTC |
Tansey Casey MDirector
|
GrantCommon Stock | 62 | $218.45 | $13,543.90 |
DisclosureSEC source: 0001104659-21-049761 · tm2112723-1_4seq1.xml · nonDerivative · entry 1 Tansey Casey M · CIK 0001474322 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,067 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 20:11 UTC |
Buchholz RichardChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,645 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · derivative · entry 15 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329 Underlying: Common Stock · 1,645 shares Expires 2027-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vested and became exercisable as to 25% of the original 15,789 underlying shares on April 1, 2018 and has vested or will vest and become exercisable with respect to the remaining 75%of the original underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F6 · balance_after: Prior Form 4s dated July 23, 2020 and October 13, 2020 previously misstated the number of remaining shares underlying this option award and such number has been corrected in this Form 4. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 20:11 UTC |
Buchholz RichardChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 376 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · derivative · entry 14 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 376 shares Expires 2027-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 20:11 UTC |
Buchholz RichardChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,350 | $0.00 Strike: $10.38 | $0.00 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · derivative · entry 13 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,109 Underlying: Common Stock · 2,350 shares Expires 2028-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested and became exercisable as to 25% of the original 22,556 underlying shares on April 9, 2019 and has vested or will vest and become exercisable with respect to the remaining 75% of the original underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 20:11 UTC |
Buchholz RichardChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,095 | $0.00 Strike: $42.15 | $0.00 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · derivative · entry 12 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,459 Underlying: Common Stock · 6,095 shares Expires 2028-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested and became exercisable as to 25% of the original 25,000 underlying shares on December 18, 2019 and has vested or will vest and become exercisable with respect to the remaining 75% of the original underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 20:11 UTC |
Buchholz RichardChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,034 | $0.00 Strike: $71.00 | $0.00 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · derivative · entry 11 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,966 Underlying: Common Stock · 2,034 shares Expires 2029-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested and became exercisable as to 25% of the original 20,000 underlying shares on December 16, 2020 and has vested or will vest and become exercisable with respect to the remaining 75% of the original underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 20:11 UTC |
Buchholz RichardChief Financial Officer
|
Exercise / conversionCommon Stock | 1,645 | $0.94 | $1,546.30 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · nonDerivative · entry 10 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,789 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 20:11 UTC |
Buchholz RichardChief Financial Officer
|
Exercise / conversionCommon Stock | 376 | $0.94 | $353.44 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · nonDerivative · entry 9 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,144 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 20:11 UTC |
Buchholz RichardChief Financial Officer
|
Exercise / conversionCommon Stock | 2,350 | $10.38 | $24,393.00 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · nonDerivative · entry 8 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,768 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 20:11 UTC |
Buchholz RichardChief Financial Officer
|
Exercise / conversionCommon Stock | 6,095 | $42.15 | $256,904.25 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · nonDerivative · entry 7 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,418 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 20:11 UTC |
Buchholz RichardChief Financial Officer
|
Exercise / conversionCommon Stock | 2,034 | $71.00 | $144,414.00 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · nonDerivative · entry 6 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,323 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2021 Filed Mar 1, 2021 22:41 UTC |
Jandrich StevenVP, Human Resources
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 445 | $0.00 Strike: $10.38 | $0.00 |
DisclosureSEC source: 0001104659-21-030173 · tm218265-2_4seq1.xml · derivative · entry 7 Jandrich Steven · CIK 0001737203 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,086 Underlying: Common Stock · 445 shares Expires 2028-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested and became exercisable as to 25% of the original 7,518 underlying shares on April 9, 2019 and the remaining 75% of the underlying shares have vested or will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 26, 2021 Filed Mar 1, 2021 22:41 UTC |
Jandrich StevenVP, Human Resources
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,555 | $0.00 Strike: $42.15 | $0.00 |
DisclosureSEC source: 0001104659-21-030173 · tm218265-2_4seq1.xml · derivative · entry 6 Jandrich Steven · CIK 0001737203 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,987 Underlying: Common Stock · 9,555 shares Expires 2028-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested and became exercisable as to 25% of the original 25,000 underlying shares on December 18, 2019 and the remaining 75% of the underlying shares have vested or will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 26, 2021 Filed Mar 1, 2021 22:41 UTC |
Jandrich StevenVP, Human Resources
|
SaleCommon Stock | 10,000 | $235.00 | $2,350,000.00 |
DisclosureSEC source: 0001104659-21-030173 · tm218265-2_4seq1.xml · nonDerivative · entry 3 Jandrich Steven · CIK 0001737203 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,505 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 26, 2021 Filed Mar 1, 2021 22:41 UTC |
Jandrich StevenVP, Human Resources
|
Exercise / conversionCommon Stock | 445 | $10.38 | $4,619.10 |
DisclosureSEC source: 0001104659-21-030173 · tm218265-2_4seq1.xml · nonDerivative · entry 2 Jandrich Steven · CIK 0001737203 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,505 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2021 Filed Mar 1, 2021 22:41 UTC |
Jandrich StevenVP, Human Resources
|
Exercise / conversionCommon Stock | 9,555 | $42.15 | $402,743.25 |
DisclosureSEC source: 0001104659-21-030173 · tm218265-2_4seq1.xml · nonDerivative · entry 1 Jandrich Steven · CIK 0001737203 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 22:39 UTC |
Buchholz RichardChief Financial Officer
|
SaleCommon Stock | 400 | $228.30 | $91,318.00 |
DisclosureSEC source: 0001104659-21-030172 · tm218265-1_4seq1.xml · nonDerivative · entry 6 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,769 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.18 to $228.49. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 22:39 UTC |
Buchholz RichardChief Financial Officer
|
SaleCommon Stock | 1,000 | $227.44 | $227,440.00 |
DisclosureSEC source: 0001104659-21-030172 · tm218265-1_4seq1.xml · nonDerivative · entry 5 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,169 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.18 to $228.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 22:39 UTC |
Buchholz RichardChief Financial Officer
|
SaleCommon Stock | 4,401 | $226.68 | $997,618.68 |
DisclosureSEC source: 0001104659-21-030172 · tm218265-1_4seq1.xml · nonDerivative · entry 4 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,169 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.16 to $227.13. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 22:39 UTC |
Buchholz RichardChief Financial Officer
|
SaleCommon Stock | 7,817 | $225.74 | $1,764,609.58 |
DisclosureSEC source: 0001104659-21-030172 · tm218265-1_4seq1.xml · nonDerivative · entry 3 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,570 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.14 to $226.12. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 22:39 UTC |
Buchholz RichardChief Financial Officer
|
SaleCommon Stock | 5,682 | $224.78 | $1,277,199.96 |
DisclosureSEC source: 0001104659-21-030172 · tm218265-1_4seq1.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,387 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.14 to $225.11. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 22:39 UTC |
Buchholz RichardChief Financial Officer
|
SaleCommon Stock | 700 | $223.74 | $156,618.00 |
DisclosureSEC source: 0001104659-21-030172 · tm218265-1_4seq1.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,069 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.13 to $224.10. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 118 shares acquired under the Company's 2018 Employee Stock Purchase Plan since the date of the reporting person's last ownership report. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.